ZA952169B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA952169B
ZA952169B ZA952169A ZA952169A ZA952169B ZA 952169 B ZA952169 B ZA 952169B ZA 952169 A ZA952169 A ZA 952169A ZA 952169 A ZA952169 A ZA 952169A ZA 952169 B ZA952169 B ZA 952169B
Authority
ZA
South Africa
Prior art keywords
colon
delivery system
polymer layer
erodible polymer
drug
Prior art date
Application number
ZA952169A
Other languages
English (en)
Inventor
Wantanee Phuapradit
Aruna Railkar
Navnit Hargovindas Shah
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA952169B publication Critical patent/ZA952169B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radar Systems Or Details Thereof (AREA)
ZA952169A 1994-03-23 1995-03-16 Pharmaceutical compositions ZA952169B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/217,344 US5482718A (en) 1994-03-23 1994-03-23 Colon-targeted delivery system

Publications (1)

Publication Number Publication Date
ZA952169B true ZA952169B (en) 1995-09-26

Family

ID=22810676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952169A ZA952169B (en) 1994-03-23 1995-03-16 Pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5482718A (zh)
EP (1) EP0673645B1 (zh)
JP (1) JP2774080B2 (zh)
CN (1) CN1112417A (zh)
AT (1) ATE205705T1 (zh)
AU (1) AU696943B2 (zh)
CA (1) CA2142653A1 (zh)
DE (1) DE69522729T2 (zh)
DK (1) DK0673645T3 (zh)
ES (1) ES2162874T3 (zh)
NZ (1) NZ270737A (zh)
PH (1) PH31334A (zh)
PT (1) PT673645E (zh)
RU (1) RU2138251C1 (zh)
ZA (1) ZA952169B (zh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2882201A (en) * 2000-01-27 2001-08-07 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
EP1275373A4 (en) 2000-04-17 2007-04-04 Astellas Pharma Inc DRUG DISPERSION SYSTEM FOR THE AVOIDANCE OF PHARMACOKINETIC INTERACTIONS BETWEEN ACTIVE SUBSTANCES AND METHODOLOGY THEREOF
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
JP2004529902A (ja) * 2001-03-13 2004-09-30 ペンウェスト ファーマシューティカルズ カンパニー グルココルチコステロイドを含有する時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
EP1455751A1 (en) * 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20070042143A1 (en) * 2003-04-23 2007-02-22 Ferring B.V. Sachet for a pharmaceutical composition
ATE512659T1 (de) 2003-04-24 2011-07-15 Jagotec Ag Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
MXPA06002300A (es) * 2003-09-03 2006-05-19 Mallinckrodt Inc Preparacion granular de liberacion sostenida y produccion de la misma.
AP2006003585A0 (en) * 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
JP2007519608A (ja) * 2003-09-19 2007-07-19 ペンウェスト ファーマシューティカルズ カンパニー 時間治療用剤形
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
KR101430089B1 (ko) 2006-08-03 2014-08-13 호라이즌 파르마 에이쥐 류마티스 질환의 지연-방출형 글루코코르티코이드 치료제
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
GB0900350D0 (en) * 2009-01-09 2009-02-11 Cambridge Entpr Ltd Formulations of viable bacteria for oral delivery
CN102784203A (zh) * 2011-05-20 2012-11-21 上海凯宝药业股份有限公司 一种痰热清片剂及其制备方法
AU2012305915B2 (en) 2011-09-07 2017-09-07 Roland Saur-Brosch Formulation for the controlled release of one or several substances in the digestive tract of a mammal
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
JP6294457B2 (ja) 2013-03-15 2018-03-14 ワーナー チルコット カンパニー， エルエルシーＷａｒｎｅｒ Ｃｈｉｌｃｏｔｔ Ｃｏｍｐａｎｙ， Ｌｌｃ 低減した送達変動性のための複数の投薬要素を備えるメサラミン医薬組成物
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
EP3612196A4 (en) 2017-04-18 2021-01-13 Actorius Innovations and Research Pvt. Ltd. POLYMER-BASED FORMULATION FOR THE RELEASE OF DRUGS AND BIOACTIVE PRODUCTS AT SPECIFIC GIT SITES
US11524029B2 (en) 2018-08-13 2022-12-13 Viscera Labs, Inc. Therapeutic composition and methods
US11590161B2 (en) 2018-08-13 2023-02-28 Viscera Labs, Inc. Therapeutic composition and methods
EP3662902A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
WO2021163007A1 (en) * 2020-02-12 2021-08-19 Viscera Labs, Inc. Therapeutic composition and methods
US11896719B2 (en) * 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Also Published As

Publication number Publication date
PH31334A (en) 1998-07-06
DE69522729D1 (de) 2001-10-25
RU2138251C1 (ru) 1999-09-27
EP0673645A3 (en) 1996-07-24
EP0673645B1 (en) 2001-09-19
JPH07277958A (ja) 1995-10-24
JP2774080B2 (ja) 1998-07-09
DK0673645T3 (da) 2001-11-12
ES2162874T3 (es) 2002-01-16
DE69522729T2 (de) 2002-07-04
EP0673645A2 (en) 1995-09-27
AU1488295A (en) 1995-10-05
CA2142653A1 (en) 1995-09-24
AU696943B2 (en) 1998-09-24
ATE205705T1 (de) 2001-10-15
US5482718A (en) 1996-01-09
PT673645E (pt) 2002-03-28
CN1112417A (zh) 1995-11-29
NZ270737A (en) 1996-11-26

Similar Documents

Publication Publication Date Title
ZA952169B (en) Pharmaceutical compositions
US5681584A (en) Controlled release drug delivery device
MX9500885A (es) Preparacion farmaceutica para administracion oral.
CA2335566A1 (en) Effervescent drug delivery system for oral administration
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
ATE238774T1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
DE3686936T2 (de) Am zielorgan wirkendes enterales abgabesystem.
ATE285228T1 (de) Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt
ATE279914T1 (de) Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt
DE69517218T2 (de) Kontrolliertes pharmazeutisches Präparat zur gezielten Freisetzung eines medizinischen Wirkstoffes im Intestinaltrakt
ATE261301T1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel
HK1038701A1 (zh) 口脈冲劑量藥物釋放系統
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
GR3018455T3 (en) Delayed release oral dosage forms for treatment of intestinal disorders.
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
ES2135570T3 (es) Composicion para la administracion oral de peptidos.
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน
MY114610A (en) Controlled drug delivery system for diltiazem.